BUY Neogen Chemicals Limited — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)29 Jul 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 other SEBI-registered advisor has an active long-term BUY call on this stock
Advisor consensus · same horizon·29 Jul · 3w ago
Neogen Chemicals reported strong financial results for the period ending July 26, 2026. Revenue increased by 34% year-on-year to INR 250 crore, and Profit After Tax (PAT) rose by 67% year-on-year to I
NSE · Press Release·26 Jul · 3w ago
Neogen Chemicals reported strong Q1 FY27 financial results with revenues at INR 250 crore (up 34% YoY) and PAT at INR 17 crore (up 67% YoY). The company also announced plans to raise up to INR 600 cro
BSE · Company Update·26 Jul · 3w ago
Neogen Chemicals, Rishabh Instruments in Focus as Markets Edge Up
NewsGoogle News·11 Aug · 6d ago
The company's board approved financials for Q1 FY27, statement of deviation, integrated annual report for FY26, and fixed the record date and book closure period.
BSE · Company Update·24 Jul · 3w ago
The company's board approved financials for Q1 FY27, statement of deviation, integrated annual report for FY26, and fixed the record date and book closure date.
BSE · Board Meeting·24 Jul · 3w ago
Neogen Chemicals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
NSE · Outcome of Board Meeting·24 Jul · 3w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Neogen Chemicals
- BUY — Antique Stock Broking19 Oct 2026 · ~1 year · target ₹3,050 · Active
- BUY — ICICI Securities28 Sept 2026 · ~1 year · target ₹2,765 · Target hit
- BUY — Kunal Saraogi18 Sept 2026 · ~2 weeks · target ₹2,550 · SL hit
- BUY — Sachin Janardan Sarvade, IDBI Capital Markets and Securities16 Sept 2026 · ~1 year · target ₹3,100 · Active
- BUY — Sahi Research27 Aug 2026 · ~2 weeks · target ₹2,290 · SL hit
More from ICICI Securities
- BUY The Indian Hotels Company22 Oct 2026 · ~1 year · target ₹969 · Active
- BUY Just Dial21 Oct 2026 · ~1 year · target ₹850 · Active
- BUY Union Bank of India20 Oct 2026 · ~1 year · target ₹230 · Active
- BUY Rossari Biotech20 Oct 2026 · ~1 year · target ₹520 · Active
- BUY Tatva Chintan Pharma Chem20 Oct 2026 · ~1 year · target ₹2,385 · Active

